Alteplase injection
Ended Awarded Last action
- Contract number
- SPE2DX25FRVLM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $28,371
Award facts
- Contract value 100% obligated
- $28,371.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$9 | |
| Original award | $28,381 |
About this award
The Defense Logistics Agency Medical Supply Chain awarded a $28,371.41 delivery order to AmerisourceBergen Drug Corp for Alteplase Injection on December 11, 2024, with completion scheduled for January 8, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under a larger indefinite delivery vehicle and will be performed at the contractor's Conshohocken, Pennsylvania location. Alteplase is a thrombolytic agent used for acute myocardial infarction and stroke treatment, and this order fulfills critical pharmaceutical supply requirements for military healthcare operations.
This delivery order is issued as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems. AmerisourceBergen is a major pharmaceutical distributor and the incumbent prime vendor for this DLA program, though the agency is planning next-generation contracts with potential multiple award strategies across separate regions.
Quick answers
Who was awarded contract SPE2DX25FRVLM?
SPE2DX25FRVLM was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on December 11, 2024.
How much is contract SPE2DX25FRVLM worth?
The government has obligated $28,371 on SPE2DX25FRVLM.
Is contract SPE2DX25FRVLM an order under another contract?
Yes. SPE2DX25FRVLM is a delivery order under SPE2DX15D1901, an indefinite delivery contract.
Was contract SPE2DX25FRVLM competed?
The extent of competition for SPE2DX25FRVLM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award